http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104540830-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2013-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17b1829fb6b1354f0ca02010cd34f32c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ff91b47c43b054d01fd9343d9fb061a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3726606a9580c0e9b0e170135449acdb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd66e2cca5cb51bcb2c893734e9db9de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aeb21109021ea80268b24021e62a706a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c195cfa592de80627a6c3aad0d51c1d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_470d472bac78cf28c6e1508ebb2de45c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c616320db2c9d12f9af9947557c1e8d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfd0fb8acd03a1b755e91cc20224027f
publicationDate 2015-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104540830-A
titleOfInvention Pyrazolopyrimidone and pyrazolopyridone inhibitors of tankyrase
abstract The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein Q, R 1 and R 2 are as defined in the description. The compounds of formula I are useful in the treatment of cancer.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112830929-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112830929-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114341125-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107286169-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107286169-A
priorityDate 2012-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6200980-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010118367-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1396488-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101675051-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3720674-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-937725-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59822754
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467978423
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430442694
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107289882
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430461407
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416193980
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID108168099
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414991663
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466482292
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419652597
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135484677
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468185755
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467410886
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2782793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466587595
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466445176

Total number of triples: 56.